Resmonics AG

Information

500+ million people suffer from chronic respiratory diseases. Our CE-certified solution, ResGuard Med, enables these patients to monitor their disease with unprecedented convenience: Patients simply need to keep their smartphone in their bedroom at night to monitor their disease and receive alerts in times of medical need.

At Resmonics, we believe there are already enough health apps out there. That's why we offer ResGuard Med as a software component that can be integrated into existing apps. Our customers benefit from our 5 years of AI and respiratory medicine research at leading Swiss universities and healthcare providers.